Abstract
Poorly controlled gastroesophageal reflux is implicated as a risk factor for recurrence of Barrett esophagus (BE) after endoscopic eradication therapy (EET), recently estimated at an annual rate of 9.6% (NEJM JW Gastroenterol Nov 9 2016; [e-pub] and Am J Gastroenterol 2017; 112:87). However, the magnitude of the effect is unclear. In a single-center observational study, researchers assessed complete eradication of intestinal metaplasia and its recurrence in 221 consecutive patients with BE who were managed with …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
